ctDNA SNORD3F Hypermethylation is a Prognostic Indicator in EGFR-TKI-Treated Advanced Non-Small Cell Lung Cancer
Introduction Lung cancer accounts for approximately 18% of global cancer deaths, with non-small cell lung cancer (NSCLC) accounting for 80% to 85% of cases.1 Epidermal growth factor receptor (EGFR) is a key oncogenic driver in NSCLC, with over 40% of …